Market news
Detailed price information for Unicycive Therapeutics Inc (UNCY-Q) from The Globe and Mail including charting and trades.
NewMediaWire Press Release.
Detailed price information for Unicycive Therapeutics Inc (UNCY-Q) from The Globe and Mail including charting and trades.
LOS ALTOS, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 11 a.m. ET. A link to the live and archived webcast may be accessed on the Unicycive website unde
Detailed price information for Tempus AI Cl A (TEM-Q) from The Globe and Mail including charting and trades.
Unicycive Therapeutics (UNCY) has an average rating of buy and mean price target of $31.30, accordin
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) shares gained 2.
ACN Newswire Press Release.
Tipranks Press Release.
This is the newest page. Registered accounts read further back.